Latest Fragile X syndrome Stories
CORAL SPRINGS, Florida, April 20, 2015 /PRNewswire/ -- In the search for neuroscience drug discovery treatments, Alzheimer's disease and specifically autism drug candidates,
Studies to evaluate the effects of bryostatin-1 in a Fragile X Syndrome mouse model over a thirteen week period NEWARK, N.J., Apr. 20, 2015 /PRNewswire/ -- Neurotrope, Inc.
CORAL SPRINGS, Florida, April 9, 2015 /PRNewswire/ -- According to a recent article [http://blogs.wsj.com/pharmalot/2014/09/29/high-prices-for-orphan-drug-can-be-sustained-a-payer-survey-shows
Randi Hagerman, medical director of the UC Davis MIND Institute, has received the prestigious International Sisley-Lejeune Award 2014 from the Paris-based Jérôme Lejeune Foundation.
RnRMarketResearch.com adds Fragile X Syndrome Pipeline Review H2 2014 to its store.
Researchers with the UC Davis MIND Institute will develop and evaluate tests designed to measure and track changes in the cognitive functioning of people who typically are difficult to assess
UC Davis MIND Institute medical director honored with one of the most prestigious awards for pediatricians in the United States. SACRAMENTO, Calif.
WALNUT CREEK, Calif., Aug.
Scientists studying the most common form of inherited mental disability—a genetic disease called “Fragile X syndrome”—have uncovered new details about the cellular processes responsible for the condition that could lead to the development of therapies to restore some of the capabilities lost in affected individuals.
Researchers at UC Davis have identified a new feature of the genetic mutation responsible for the progressive neurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS) — the formation of "R-loops," which they believe may be associated with the disorder's neurological symptoms, such as tremors, lack of balance, features of Parkinsonism, and cognitive decline.
- An armed gangster.